Latest Metformin Stories
DALLAS, December 10, 2014 /PRNewswire/ -- ReportsnReports.com adds Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes
The Lack of Reimbursement for DPP-IV Inhibitors and GLP-1 Analogues Hinders Their Uptake Among Chinese Patients, According to Findings from Decision Resources Group BURLINGTON, Mass., Dec.
This November, Medicationdiscountcard.com (MDC) will highlight its discount cards for diabetic medications.
New evidence helps guide first line diabetes therapy selection given limited comparative effectiveness data WOONSOCKET, R.I., Oct.
RIDGEFIELD, Conn. and INDIANAPOLIS, Oct. 21, 2014 /PRNewswire/ -- The U.S.
Fad diets come and go, but might there be something to the ones that involve consuming grapefruit and grapefruit juice? New UC Berkeley research suggests that a closer look at grapefruit juice is warranted.
-- Reducing Incidence of Limiting Side Effects Could Increase the Utility of this Effective, Safe and Affordable Therapy -- BROOMFIELD, Colo., Sept.
Results from Phase 2b Clinical Study in Patients with Type 2 Diabetes Provide Evidence that SGLT1 inhibition with LX4211 Provides a Clinically Meaningful Benefit THE WOODLANDS, Texas,
A recently-published literature review reveals that people with prediabetes have a 15 percent higher risk of developing cancer — and the level of risk differs depending on the type of cancer.
No overall statistically significant increased risk of bladder cancer in patients ever exposed to pioglitazone in a completed 10-year epidemiological study OSAKA, Japan, Aug.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.